YAP1/TEAD transcriptional complex inhibitor (Merck & Co)

N/A

Report date: 2025/06/11 10:35:18
NME

Base Information

Drug NameYAP1/TEAD transcriptional complex inhibitor (Merck & Co)
Drug Alias NameYAP1/TEAD (Merck)
ClassificationSmall molecules
Mechanisms of ActionTranscriptional enhancer factor inhibitorsTranscriptional coactivator YAP1 inhibitors
TargetsTranscriptional coactivator YAP1Transcriptional enhancer factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A